Similar Search Results

Chlamydia trachomatis in Adolescents and Adults: Clinical and Economic Implications

Marra, Carlo A.; Patrick, David M.; Reynolds, Robert; … - In: PharmacoEconomics 13 (1998) 2, pp. 191-222

Chlamydia trachomatis infections in adolescents and adults, together with a critical review of economic studies published on … all patients is also cost effective; however, it may not be feasible for all health systems. A single dose of azithromycin …

Persistent link: https://www.econbiz.de/10005449226

Outpatient Parenteral Antibacterial Therapy of Serious Infections: The Role of Ceftriaxone

Barman Balfour, Julia A.; Lamb, Harriet M. - In: Disease Management and Health Outcomes 4 (1998) 4, pp. 225-236

Outpatient parenteral antibacterial therapy (OPAT) is an increasingly popular means of containing the costs of antibacterial therapy, by avoiding the need for hospitalisation or allowing early discharge from hospital, in patients with serious infections. It also offers increased comfort and...

Persistent link: https://www.econbiz.de/10004990310

The Clinical and Economic Potential of Cyclosporin Drug Interactions

Martin, Jill E.; Daoud, A. Jamal; Schroeder, Timothy J.; … - In: PharmacoEconomics 15 (1999) 4, pp. 317-337

blockers, diltiazem, verapamil and nicardipine; and the macrolide antibacterials, erythromycin and related compounds. Although …

Persistent link: https://www.econbiz.de/10005449102

Socioeconomics of a Global Leprosy Eradication Programme

Naik, Sharad S.; Ganapati, Ramaswamy - In: PharmacoEconomics 13 (1998) 6, pp. 677-686

In the absence of evidence in the literature on cost factors in the management of leprosy, a reference is made to the sporadic attempts to study costs of case detection and treatment. Such studies indicate that in the currently declining phase of leprosy endemicity, employing a conventionally...

Persistent link: https://www.econbiz.de/10005404853

Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections

Holliday, Stephen M.; Benfield, Paul - In: PharmacoEconomics 13 (1998) 3, pp. 359-377

Meropenem is a carbapenem antibiotic which is active against the majority of aerobic and anaerobic bacteria implicated in serious infections. Its therapeutic efficacy in a wide range of serious infections is similar to that of imipenem/cilastatin and standard combination drug regimens. Hence,...

Persistent link: https://www.econbiz.de/10005590296

Management of Community-Acquired Pneumonia: The Role of Clarithromycin

Barman Balfour, Julia A.; Lamb, Harriet M. - In: Disease Management and Health Outcomes 6 (1999) 4, pp. 225-239

Legionella spp. Clarithromycin has similar efficacy to erythromycin in adults and children with mild to moderate CAP but is …In patients with community-acquired pneumonia (CAP), it is uncommon for the causative pathogen to be identified when … which covers the major pathogens of CAP. Although Streptococcus pneumoniae remains the most common pathogen in …

Persistent link: https://www.econbiz.de/10005448917

Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS: An Overview and Methodological Discussion

Freedberg, Kenneth A.; Paltiel, A. David - In: PharmacoEconomics 14 (1998) 2, pp. 165-174

Dramatic progress has recently been made in defining the pathogenesis and treatment of HIV infection. For the first time in the history of the AIDS epidemic, clinicians have at their disposal an understanding of the replication kinetics of HIV, reliable assays to measure viral load, an...

Persistent link: https://www.econbiz.de/10005449227

Economic Evaluation of Antibacterials in the Treatment of Acute Sinusitis

Laurier, Claudine; Lachaine, Jean; Ducharme, Murray - In: PharmacoEconomics 15 (1999) 1, pp. 97-113

. Interventions: The antibacterials studied were amoxicillin, amoxicillin/clavulanate, azithromycin, cefaclor, cefuroxime axetil and … costs when compared with the other antibacterials. Low dosages of clarithromycin and azithromycin followed amoxicillin in … medications. Setting: The study pertained to adults treated in a primary-care setting in the Canadian province of Quebec …

Persistent link: https://www.econbiz.de/10004990334

Point-of-Care Testing in Oral Anticoagulant Monitoring: Implications for Patient Management

Sickels, Jennifer; Lafata, Jennifer Elston; Ansell, Jack E. - In: Disease Management and Health Outcomes 6 (1999) 5, pp. 291-301

Capillary whole blood point-of-care instruments for prothrombin time testing have been available for the last 10 years for use both in an office or hospital setting as well as at home by patients for self-monitoring of oral anticoagulant therapy. There are currently 4 types of instruments...

Persistent link: https://www.econbiz.de/10005448928

Cyclosporin Microemulsion (Neoral(R)) Use of trade name is for product identification, and does not imply endorsement.: A Pharmacoeconomic Review of its Use Compared with Standard...

Coukell, Allan J.; Plosker, Greg L. - In: PharmacoEconomics 14 (1998) 6, pp. 691-708

Cyclosporin microemulsion (Neoral(R)) is a self-emulsifying preconcentrate of cyclosporin which is more rapidly and consistently absorbed than the original oil-based formulation of cyclosporin (standard formulation; Sandimmun(R), Sandimmune(R)). This superior pharmacokinetic profile suggests...

Persistent link: https://www.econbiz.de/10005449018

1
2
3
4
5
6
7
8
9
10
Next
Last